glp 1 and biologics The World's First GCG/GLP-1 Dual Agonist It Takes Two: Combining Biologics
Description
2025;68(01):e20
When low-and-slow dosing (or staying at the starting dose) makes sense and why not everyone needs aggressive escalation
It was also shown to have positive outcomes in a cardiovascular outcomes trial [22]
Cosentino F, Grant PJ, Aboyans V, et al
I was putting on a brave face, but inside I was frustrated and disappointed
doi: 10.1161/atv.0000615456.97862.30 20 HendartoH.InoguchiT.MaedaY.IkedaN.ZhengJ.TakeiR.et al
